Glenmark Life Sciences Limited
NSE:GLS.NS
Overview | Financials
Company Name | Glenmark Life Sciences Limited |
Symbol | GLS.NS |
Currency | INR |
Price | 1,096.1 |
Market Cap | 134,308,421,300 |
Dividend Yield | 2.74% |
52-week-range | 620.2 - 1,335.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Yasir Yusufali Rawjee Ph.D. |
Website | https://www.glenmarklifesciences.com |
An error occurred while fetching data.
About Glenmark Life Sciences Limited
Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD